{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-25-007879","form_type":"8-K","ticker":"ABUS","cik":"0001447028","company_name":"Arbutus Biopharma Corp","filed_at":"2025-12-11T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.431595+00:00","generated_at":"2026-05-16T13:29:26.892985+00:00","sec_items":["8.01","9.01"],"event_type":"litigation","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Arbutus updates LNP litigation; Moderna trial March 2026, Pfizer/BioNTech awaits scheduling","bullets":["Global COVID-19 vaccine sales since launch total ~$145BN between Moderna and Pfizer/BioNTech.","US Moderna jury trial set for March 9, 2026 in Delaware; summary judgment/Daubert rulings expected before trial.","Ex-US Moderna litigation initial hearings expected in 2026 in UPC, Japan, Switzerland, Canada.","Pfizer/BioNTech litigation: Markman ruling in Sep 2025 viewed favorably; awaiting trial scheduling."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-25-007879","json":"https://secwatch.observer/filing/0001171843-25-007879.json","markdown":"https://secwatch.observer/filing/0001171843-25-007879.md","text":"https://secwatch.observer/filing/0001171843-25-007879.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1447028/000117184325007879/0001171843-25-007879-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1447028/000117184325007879/f8k_121025.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T13:29:26.892985+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}